Lipid Transport Assessment
Lipid Transport Assessment - Related Videos
07:00
Using Caco-2 Cells to Study Lipid Transport by the Intestine
0 Views •
Cited by 11 •
2015
Caco-2 cells can serve as an in vitro model to study the enterocyte transport of lipids, and lipid-soluble drugs/vitamins. The permeable membrane system separates the apical from the basolateral compartment, while the lentivirus expression system offers an effective gene overexpression method. The isolation of lipoproteins is confirmed by TEM.
12:25
A Step-by-step Method for the Reconstitution of an ABC Transporter into Nanodisc Lipid Particles
0 Views •
Cited by 23 •
2012
Nanodiscs are small discoid particles that incorporate membrane proteins into a small patch of phospholipid bilayer. We provide a visual protocol that shows the step-by-step incorporation of the MalFGK2 transporter into a disc.
09:48
Original Experimental Approach for Assessing Transport Fuel Stability
0 Views •
Cited by 5 •
2016
Oxidation stability of transport fuels has become a concern for future fuel development. This work presents an original methodology developed by IFP Energies Nouvelles for assessing fuel stability using two different reactors. This methodology was successfully applied to gain an in-depth understanding of the oxidation kinetics and pathways of model molecules and commercial fuels.
13:17
The Mesenteric Lymph Duct Cannulated Rat Model: Application to the Assessment of Intestinal Lymphatic Drug Transport
0 Views •
Cited by 48 •
2015
Here we describe a technique to cannulate the mesenteric lymph duct in rats which enables quantification of lipid and drug transport via the lymphatic system following intestinal delivery. The technique can be adapted to assess mesenteric lymph concentrations and/or transport of fluid, immune cells, peptides, proteins and lipophilic molecules.
03:37
Lipid Droplet Staining of Larval Drosophila Oenocytes: A Technique for Assessment of Lipid Droplet Accumulation Under Normal and Stressed Condition Using BODIPY-Based Dye
0 Views •
2025
This video demonstrates lipid droplet staining in Drosophila larval oenocytes - hepatocyte-like cells - using the lipophilic fluorescent BODIPY based dye. These cells act as a model for studying lipid metabolism during development and in response to environmental stress such as starvation.
FAQs
The assessment considers how lipoproteins and lipid-binding proteins keep poorly water-soluble lipids mobile in biological fluids, then how receptors regulate their entry into cells. These linked steps help distinguish changes in extracellular transport from changes in cellular uptake. Examining both processes can clarify whether altered lipid availability reflects circulation, receptor-mediated entry, or redistribution within tissues.
Because lipids are poorly soluble in water, their movement cannot be interpreted as simple free diffusion through biological fluids. Carrier proteins and lipoproteins influence how much lipid remains available for delivery, while intracellular trafficking affects subsequent redistribution. Consequently, an assessment should relate measured transport to carrier-dependent circulation, cellular entry, and tissue-level allocation rather than viewing these stages in isolation.
Changes in lipid availability or membrane composition can influence immune-related signaling during activation or infection. Pathogens and host responses may alter transport, uptake, or redistribution, thereby changing the lipid environment in which signaling occurs. Lipid transport assessment helps connect these metabolic shifts with inflammatory signaling and provides a way to investigate host-pathogen interactions beyond pathogen abundance alone.
A useful assessment follows lipid movement across three linked locations: biological fluids, cells, and tissues. It examines carriage through fluids, entry into cells, and redistribution after uptake. Considering these stages together helps identify where transport changes occur and supports interpretation of whether an observed shift reflects altered availability, cellular handling, or tissue distribution.
Researchers can apply lipid transport assessment when immune activation or pathogen exposure is suspected to change lipid availability, membrane composition, or inflammatory signaling. Comparing transport patterns under these conditions can reveal metabolic consequences of disease and strengthen analysis of host-pathogen interactions. The approach is therefore relevant when lipid handling may connect cellular responses with broader tissue-level changes.
The resulting measurements can characterize disease-associated changes in lipid movement and distribution, including shifts linked to immune activation or pathogens. These data may clarify how altered lipid handling contributes to host-pathogen interactions and inflammatory signaling. They can also support evaluation of potential diagnostic or therapeutic targets by identifying transport-related changes associated with disease.